Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 4/20 | 0.49 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8490463 | 0.88 | CHEK2 (0.53) | CHEK2PTPN1ACHEOPRK1 | |
| SCHEMBL8488729 | 0.84 | ADRB2 (0.46) | ACHE | |
| SCHEMBL8491305 | 0.82 | CHEK2 (0.47) | CHEK2MCHR1KCNH2 | |
| SCHEMBL8490356 | 0.82 | KDM2B (0.51) | CHEK2 | |
| SCHEMBL6602020 | 0.82 | ESR1 (0.56) | CHEK2ACHEBCHE | |
| SCHEMBL10608375 | 0.81 | SIGMAR1 (0.61) | ACHESIGMAR1 | |
| Maleic Acid SCHEMBL10609959 | 0.79 | SIGMAR1 (0.54) | CHEK2ACHESLC18A3BCHEMCHR1 | |
| Fumaric Acid SCHEMBL10609966 | 0.79 | SIGMAR1 (0.54) | CHEK2ACHESLC18A3BCHEMCHR1 | |
| SCHEMBL8489816 | 0.79 | ALDH1A1 (0.52) | CHEK2MCHR1CHRM3 | |
| SCHEMBL8490467 | 0.79 | CHRM3 (0.44) | CHRM3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999015521-A1 | BENZOTHIOPHENES | ELI LILLY AND COMPANY (US) | 1999-04-01 | — | — | WO | disclosed |